IVF research conducted by Kew scientist Professor Lois Salamonsen has received international recognition.
Professor Salamonsen heads a team of scientists at Prince Henry’s Institute (PHI), Australia’s leading centres for reproductive health and endocrine research, who have been researching ways to improve successful pregnancy rates for IVF.
The team were the first non-European scientists to be recognised in the recent annual Merck Serono’s Grant for Fertility Innovation (GFI) awards presented in Istanbul.
“This award is a tremendous honour and I am extremely proud to receive this on behalf of all the researchers from Prince Henry’s Institute and Monash IVF who are contributing to this innovative and crucial fertility research,” Professor Salamonsen said.
The research was seeking to understand how and when the lining of the uterus was receptive to the implantation of an embryo.
“We know that receptivity occurs for only a very short time in each cycle; understanding the underlying factors that contribute to this, may enable us to test patients and determine the optimal time to re-implant their embryos during IVF,” Professor Salamonsen said.
“It may also lead to advancements in fertility treatments and contraceptives.”
Professor Salamonsen said the award would help fund the group’s collaborative investigation to identify endometrial receptivity markers.
Merck India - Biopharma 